Tumor Marker

Tumor markers are biological signals that can be detected in body fluids or tissue. Some are produced directly by cancer cells; others are made by the body as it responds to the presence of cancer. Common examples include CA-125, which may be elevated in ovarian cancer; HER2, a protein overexpressed in some breast cancers; and PSA, associated with prostate cancer. In breast cancer pathology, markers like Ki-67 are measured in tumor tissue itself to indicate how quickly cells are dividing.

These markers have important limitations. Many can be elevated for reasons unrelated to cancer — benign conditions, inflammation, or even certain foods can affect results. And not all cancers produce elevated markers. This is why tumor markers are most useful in context: combined with imaging, biopsy results, physical examination, and your medical history.

Where tumor markers shine most is in monitoring. Once a cancer diagnosis is established, changes in a marker level over time can give your oncology team early insight into whether treatment is working or whether cancer activity may be increasing. They are a useful tool in an ongoing conversation about your health, not a verdict in isolation.

Tumor markers can feel both reassuring and anxiety-provoking — a rising number is worrying, a falling one is encouraging. Understanding what these markers actually measure, and their limitations, helps you interpret results in the right context. A single elevated reading is rarely a definitive answer.

If your provider uses tumor markers as part of your monitoring plan, knowing what is being tracked and why gives you a way to participate actively in your follow-up care. Asking about trends over time, rather than focusing on a single number, is often the most meaningful way to think about these results.